NTTGUIDE

Telavancin

Recommendation 750 mg IV q24h probably adequate for most patients
Comments Data suggest this dose achieves efficacy targets and minimizes risk of nephrotoxicity. If higher systemic exposure is desired, consider 10 mg/kg q24h based on adjusted BW, not to exceed 1000 mg q24h (Pharmacotherapy 2023;43:226).

An unhandled error has occurred. Reload 🗙

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please reload the page.